Maynard Um
-
-
-
-
-
-
-
PAVmed (PAVM) PT Lowered to $17 at Ascendiant Capital
-
-
-
-
-
-
-
PAVmed (PAVM) Files $125M Mixed Shelf
-
-
-
-
-
-
-
Lucid Diagnostics (LUCD) Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
-
-
-
-
-
-
Lucid Diagnostics (LUCD) Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers
-
-
-
-
-
-
-
Lucid Diagnostics (LUCD) Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuardĀ® Esophageal Precancer Testing
-
466,335 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


